Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Studio City International ADR	MSC	18. nov 2024	6.22	0.00
Sturm Ruger & Co	RGR	18. nov 2024	38.01	-0.99
SU Group	SUGP	18. nov 2024	1.59	-8.62
Suburban Propane Partners LP Unit	SPH	18. nov 2024	17.84	+1.42
Sumitomo Mitsui Financial ADR	SMFG	18. nov 2024	13.93	-0.21
Summit Hotel Properties	INN	18. nov 2024	6.09	-1.62
Summit Hotel Properties E Pref	INN-E	18. nov 2024	20.86	+0.58
Summit Hotel Properties F Pref	INN-F	18. nov 2024	20.85	-0.14
Summit Materials A	SUM	18. nov 2024	48.52	+0.19
Summit Midstream	SMC	18. nov 2024	36.14	+1.69
Summit State Bank	SSBI	18. nov 2024	6.86	+1.18
Summit Therapeutics ADR	SMMT	18. nov 2024	18.98	+3.66
Sun Communities	SUI	18. nov 2024	125.27	+0.09
Sun Country Airlines	SNCY	18. nov 2024	14.61	-1.88
Sun Life Financial	SLF	18. nov 2024	60.63	+0.65
Suncar Technology Group	SDA	18. nov 2024	10.20	+10.63
SunCoke Energy	SXC	18. nov 2024	12.44	+1.72
Suncor Energy	SU	18. nov 2024	40.81	+0.82
Sundial Growers	SNDL	18. nov 2024	1.94	-0.51
Sunlands Technology A ADR	STG	18. nov 2024	6.94	+3.58
Sunlink Health Systems	SSY	18. nov 2024	0.79	-1.24
Sunnova Energy International	NOVA	18. nov 2024	3.65	-2.67
Sunoco LP Unit	SUN	18. nov 2024	53.88	+3.30
SunOpta	STKL	18. nov 2024	7.45	+2.19
Sunrise Communications ADR	SNREV	18. nov 2024	50.28	0.00
Sunrise New Energy	EPOW	18. nov 2024	0.92	+1.67
Sunrise Realty Trust	SUNS	18. nov 2024	14.93	+0.81
Sunrun	RUN	18. nov 2024	10.01	+1.21
Sunshine Biopharma	SBFM	18. nov 2024	2.29	-2.35
Sunstone Hotel Investors H Pref	SHO-H	18. nov 2024	22.90	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.